AB
Adverum Biotechnologies Inc
🇺🇸XNAS.ADVMUnited StatesHealthcare
$4.36USDdown -0.01 (-0.23%)OpenDelayed2:26 PM
Price$4.36-0.01 (-0.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00773U2078
- CUSIP
- 05337G107
Company
- Employees
- 155
- Headquarters
- Redwood City, United States
- Website
- https://adverum.com
- CEO
- Dr. Laurent Fischer M.D.
Market
- Shares outstanding
- 22.1M
- Market cap
- $96.26M
Highlights
- Market cap
- $96.26M
- EPS LTM
- -$9.26calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.47calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- -$3.6M-38.46%down year on year
- Net income
- -$204.39M-88.39%down year on year
- Gross margin
- 146.75%-40.86%down year on year
- Free cash flow
- -$138.45M-60.73%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.